Key Insights

Highlights

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00891852Unknown

Non-Invasive Determination of Fetal Chromosome Abnormalities

Showing all 1 trials

Research Network

Active Sponsors

  • Lenetix Medical Screening Laboratory1

Top Investigators

Related Conditions

  • Abnormalities1
  • Edwards Syndrome Trisomy 181
  • Down Syndrome Trisomy 211
  • Klinefelter Syndrome 47 Xxy1
  • Patau Syndrome Trisomy 131

Activity Timeline